Literature DB >> 23745734

Mucopolysaccharidosis Type IIIA presents as a variant of Klüver-Bucy syndrome.

Michael Potegal1, Brianna Yund, Kyle Rudser, Alia Ahmed, Kate Delaney, Igor Nestrasil, Chester B Whitley, Elsa G Shapiro.   

Abstract

Mucopolysaccharidosis Type IIIA (MPS IIIA) is a neurodegenerative disease with behavioral symptoms unique among the mucopolysaccharidoses. Children with MPS IIIA reportedly mouth things, explore novel environments almost continuously, disregard danger, and empathize/socialize and comply less with parents. These characteristics resemble Klüver-Bucy syndrome (K-Bs). To test the K-Bs hypothesis, 30 children with MPS IIIA were compared to 8 "posttransplant" mucopolysaccharidosis Type IH patients in an experimental "risk room." The room contained attractive and mildly frightening objects, exposure to a 92-dB startle noise triggered by contact with an attractive toy, mother's return after a brief absence, and compliance with her cleanup directive. Children with MPS IIIA: (a) left mother sooner, (b) wandered more, (c) were more likely to approach frightening objects, (d) were less likely to respond to loud noise with whole body startle, (e) were less likely to avoid the toy associated with the startle noise, (f) interacted less with mother upon her return, and (g) complied less with her cleanup command. K-Bs is associated with loss of amygdala function. Brain magnetic resonance imaging (MRI) of a subset of the children with MPS IIIA showed volume loss that was greater in the amygdala than in the hippocampus; only amygdala loss correlated with reduced fearfulness. MPS IIIA may be the first identified pediatric disease presenting systematically as a K-Bs variant. If validated by further studies, the K-Bs hypothesis of MPS IIIA would provide important clinical and theoretical information for the guidance of families as well as markers for natural disease progression and treatment effects.

Entities:  

Mesh:

Year:  2013        PMID: 23745734      PMCID: PMC3931576          DOI: 10.1080/13803395.2013.804035

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  28 in total

1.  Postcontusional Kluver-Bucy syndrome.

Authors:  Dursun Aygun; H Guven; L Altintop; Z Doganay
Journal:  Am J Emerg Med       Date:  2003-05       Impact factor: 2.469

2.  Incidence and natural history of mucopolysaccharidosis type III in France and comparison with United Kingdom and Greece.

Authors:  Bénédicte Héron; Yann Mikaeloff; Roseline Froissart; Guillaume Caridade; Irène Maire; Catherine Caillaud; Thierry Levade; Brigitte Chabrol; François Feillet; Hélène Ogier; Vassili Valayannopoulos; Helen Michelakakis; Dimitrios Zafeiriou; Lucy Lavery; Ed Wraith; Olivier Danos; Jean-Michel Heard; Marc Tardieu
Journal:  Am J Med Genet A       Date:  2011-01       Impact factor: 2.802

Review 3.  Management of mucopolysaccharidosis type III.

Authors:  M A Cleary; J E Wraith
Journal:  Arch Dis Child       Date:  1993-09       Impact factor: 3.791

4.  Auditory brainstem responses from children three months to three years of age: normal patterns of response. II.

Authors:  M P Gorga; J R Kaminski; K L Beauchaine; W Jesteadt; S T Neely
Journal:  J Speech Hear Res       Date:  1989-06

Review 5.  Clinic observations of structured parent-child interaction designed to evaluate externalizing disorders.

Authors:  M W Roberts
Journal:  Psychol Assess       Date:  2001-03

6.  Early presentation in the mucopolysaccharide disorders.

Authors:  G A Colville; M A Bax
Journal:  Child Care Health Dev       Date:  1996-01       Impact factor: 2.508

7.  Auditory brainstem responses in childhood psychosis.

Authors:  C Gillberg; U Rosenhall; E Johansson
Journal:  J Autism Dev Disord       Date:  1983-06

8.  Propofol infusion and auditory evoked potentials.

Authors:  G Savoia; C Esposito; F Belfiore; B Amantea; R Cuocolo
Journal:  Anaesthesia       Date:  1988-03       Impact factor: 6.955

9.  Double dissociation of conditioning and declarative knowledge relative to the amygdala and hippocampus in humans.

Authors:  A Bechara; D Tranel; H Damasio; R Adolphs; C Rockland; A R Damasio
Journal:  Science       Date:  1995-08-25       Impact factor: 47.728

10.  Auditory brainstem response, middle latency response, and late cortical evoked potentials in children with learning disabilities.

Authors:  Suzanne C Purdy; Andrea S Kelly; Merren G Davies
Journal:  J Am Acad Audiol       Date:  2002 Jul-Aug       Impact factor: 1.664

View more
  10 in total

1.  A Prospective Natural History Study of Mucopolysaccharidosis Type IIIA.

Authors:  Elsa G Shapiro; Igor Nestrasil; Kathleen A Delaney; Kyle Rudser; Victor Kovac; Nitin Nair; Charles W Richard; Patrick Haslett; Chester B Whitley
Journal:  J Pediatr       Date:  2016-01-16       Impact factor: 4.406

2.  Klüver-Bucy syndrome associated with a recessive variant in HGSNAT in two siblings with Mucopolysaccharidosis type IIIC (Sanfilippo C).

Authors:  Hao Hu; Christoph Hübner; Zoltan Lukacs; Luciana Musante; Esther Gill; Thomas F Wienker; Hans-Hilger Ropers; Ellen Knierim; Markus Schuelke
Journal:  Eur J Hum Genet       Date:  2016-11-09       Impact factor: 4.246

3.  Quantifying behaviors of children with Sanfilippo syndrome: the Sanfilippo Behavior Rating Scale.

Authors:  Elsa G Shapiro; Igor Nestrasil; Alia Ahmed; Andrew Wey; Kyle R Rudser; Kathleen A Delaney; Robin K Rumsey; Patrick A J Haslett; Chester B Whitley; Michael Potegal
Journal:  Mol Genet Metab       Date:  2015-03-05       Impact factor: 4.797

4.  Behavioral deficits and cholinergic pathway abnormalities in male Sanfilippo B mice.

Authors:  Shih-Hsin Kan; Steven Q Le; Quang D Bui; Braeden Benedict; Jesse Cushman; Mark S Sands; Patricia I Dickson
Journal:  Behav Brain Res       Date:  2016-06-23       Impact factor: 3.332

5.  An investigation of the middle and late behavioural phenotypes of Mucopolysaccharidosis Type-III.

Authors:  Elaine M Cross; Sheena Grant; Simon Jones; Brian W Bigger; James E Wraith; Louise V Mahon; Michelle Lomax; Dougal J Hare
Journal:  J Neurodev Disord       Date:  2014-12-31       Impact factor: 4.025

6.  The Neurobehavioral Phenotype in Mucopolysaccharidosis Type IIIB: an Exploratory Study.

Authors:  E Shapiro; K King; A Ahmed; K Rudser; R Rumsey; B Yund; K Delaney; I Nestrasil; C Whitley; M Potegal
Journal:  Mol Genet Metab Rep       Date:  2016-03-01

7.  Recommendations on clinical trial design for treatment of Mucopolysaccharidosis Type III.

Authors:  Arunabha Ghosh; Elsa Shapiro; Stewart Rust; Kathleen Delaney; Samantha Parker; Adam J Shaywitz; Adelaida Morte; Gillian Bubb; Maureen Cleary; Tien Bo; Christine Lavery; Brian W Bigger; Simon A Jones
Journal:  Orphanet J Rare Dis       Date:  2017-06-26       Impact factor: 4.123

8.  Music therapy and Sanfilippo syndrome: an analysis of psychological and physiological variables of three case studies.

Authors:  P Pérez-Núñez; E Lázaro; I Amayra; J F López-Paz; P Caballero; O Martínez; M Pérez; S Berrocoso; M Al-Rashaida; M García; A A Rodríguez; P M Luna
Journal:  Orphanet J Rare Dis       Date:  2021-11-20       Impact factor: 4.123

Review 9.  Neurobehavioral phenotypes of neuronopathic mucopolysaccharidoses.

Authors:  Rita Barone; Alessandra Pellico; Annarita Pittalà; Serena Gasperini
Journal:  Ital J Pediatr       Date:  2018-11-16       Impact factor: 2.638

Review 10.  Molecular Bases of Neurodegeneration and Cognitive Decline, the Major Burden of Sanfilippo Disease.

Authors:  Rachel Heon-Roberts; Annie L A Nguyen; Alexey V Pshezhetsky
Journal:  J Clin Med       Date:  2020-01-27       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.